|
|
|
1,001-5,000 employees
View all
|
|
biotechnology
|
|
16 GREAT QUEEN STREET,GB
|
|
Biocon Biologics is a subsidiary of Biocon Ltd, an innovation led global biopharmaceuticals company. Biocon Biologics is engaged in developing high quality, affordable biosimilars that can expand access to a cutting-edge class of therapies to patients globally. It is uniquely positioned as a fully integrated ‘pure play’ biosimilars organization in the world and aspires to transform patient lives through innovative and inclusive healthcare solutions. The Company has a large portfolio of biosimilars under global clinical development with three of these commercialized in at least one of the developed markets of EU, U.S. and Japan. Biocon Biologics has a product pipeline of 28 molecules, including 11 with Mylan, several with Sandoz and is developing many independently. Biocon Biologics believes that strong partnerships offer enormous opportunities to co-create the future of healthcare, building a patient ecosystem beyond the product, which can transform millions of lives.
|
Biocon Biologics Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
67.46%
|
The widely used Biocon Biologics email format is {first}.{last} (e.g. [email protected]) with 67.46% adoption across the company.
To contact Biocon Biologics customer service number in your country click here to find.
Shreehas Tambe is the CEO of Biocon Biologics. To contact Shreehas Tambe email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.